According to a business presentation meeting of Mitsubishi Chemical Holdings, the companies Life Sciences Institute LSII hs completed, in October, the facility for the manufacture of heterologous MUSE cells. For 2019, triple sales of biodegradable BioPBS (bio-based polybutylene succinate) are expected.

Nikkei Biotech news release, December 5, 2018